UNSPSC 51373440: Codeine/guaifenesin/pheniramine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373440 Codeine/guaifenesin/pheniramine is a Commodity code covering pharmaceutical products and related healthcare supplies procured by state and local governments, though recent solicitation activity shows limited direct alignment with the code's nominal scope. The Washington State Department of Corrections issued RFQ RFQQK13020 in September 2026 for parenteral products, services, and equipment—including parenteral nutrition solutions, intravenous solutions, and controlled substances for incarcerated individuals—with response due October 7, 2026. A separate procurement by Seminole County, Florida (IFB 60459723LAS, posted June 2026) sought naloxone and drug deactivation systems for community health initiatives. State and local buyers under this code span correctional agencies, county health departments, and public health authorities, with issuing bodies setting specific insurance and licensing requirements, pre-bid conferences, and compliance mandates such as E-Verify and drug-free workplace certification.

Recent activity appears concentrated in Washington State and Florida, with the Washington DOC procurement spanning eight correctional facilities across three regions and Seminole County planning quarterly deliveries to a single health building in Sanford. The Washington solicitation encourages small business (25%), minority-owned (10%), women-owned (6%), and veteran-owned (5%) participation under state set-aside goals and requires fixed pricing for the initial two-year contract term (November 26, 2026 through June 30, 2030), with DOC retaining discretionary extension rights through June 2030. Delivery windows are stringent—parenteral nutrition bags must arrive within 24 hours of order and other parenteral products within 8 hours for initial supply. The Seminole County procurement specified annual quantities (1,900 units of naloxone and 800 deactivation systems) with a two-year initial term and one-year renewal option but did not flag explicit set-asides for disadvantaged enterprises. Both solicitations require comprehensive insurance coverage and vendor background clearance.